tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Zealand Pharma to pay $20M upfront in OTR Therapeutics license agreement
PremiumThe FlyZealand Pharma to pay $20M upfront in OTR Therapeutics license agreement
2M ago
Zealand Pharma price target lowered to DKK 1,000 from DKK 1,050 at JPMorgan
Premium
The Fly
Zealand Pharma price target lowered to DKK 1,000 from DKK 1,050 at JPMorgan
3M ago
Zealand Pharma price target lowered to DKK 825 from DKK 850 at Berenberg
Premium
The Fly
Zealand Pharma price target lowered to DKK 825 from DKK 850 at Berenberg
3M ago
Zealand Pharma’s Petrelintide Study: A Potential Game-Changer for Diabetes Management
PremiumCompany AnnouncementsZealand Pharma’s Petrelintide Study: A Potential Game-Changer for Diabetes Management
4M ago
Zealand Pharma’s ZP9830 Study: A Potential Game-Changer in Autoimmune Treatment
Premium
Company Announcements
Zealand Pharma’s ZP9830 Study: A Potential Game-Changer in Autoimmune Treatment
4M ago
Zealand Pharma management to meet virtually with Cantor
Premium
The Fly
Zealand Pharma management to meet virtually with Cantor
4M ago
Zealand Pharma initiated with an Overweight at Wells Fargo
PremiumThe FlyZealand Pharma initiated with an Overweight at Wells Fargo
7M ago
Zealand Pharma’s Petrelintide Trial: A Potential Game-Changer in Obesity Treatment?
Premium
Company Announcements
Zealand Pharma’s Petrelintide Trial: A Potential Game-Changer in Obesity Treatment?
8M ago
Zealand Pharma initiated with an Overweight at Barclays
Premium
The Fly
Zealand Pharma initiated with an Overweight at Barclays
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100